Online inquiry

IVTScrip™ mRNA-Anti-B4GALNT1, Hu3F8(Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) (CAT#: GTTS-WQ8525MR)

This product GTTS-WQ8525MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP. It ecodes the monoclonal antibody that targets B4GALNT1 gene. The antibody can be applied in Neuroblastoma research.

Specifications
Product type	mRNA
Modified bases	5-Methyl-CTP
5' Cap	Cap 0
Species	Chimeric
RefSeq	NM_001276468.2
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	2583
UniProt ID	Q00973

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-B4GALNT1, Hu3F8(Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) (GTTS-WQ8525MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ10433MR	IVTScrip™ mRNA-Anti-MSTN, LY-2495655(Cap 1, Pseudo-UTP, 30 nt-poly(A))	mRNA	LY-2495655
GTTS-WQ5292MR	IVTScrip™ mRNA-Anti-ALCAM, CD166 AADC(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	CD166 AADC
GTTS-WQ4536MR	IVTScrip™ mRNA-Anti-PDCD1, BMS-936558(Cap 1, 2-Thio-UTP, 120 nt-poly(A))	mRNA	BMS-936558
GTTS-WQ2021MR	IVTScrip™ mRNA-Anti-INSR, AGT-181(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	AGT-181
GTTS-WQ9777MR	IVTScrip™ mRNA-Anti-PDCD1, JS001(Cap 1, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	JS001
GTTS-WQ11568MR	IVTScrip™ mRNA-Anti-CD276, MG-A271(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	MG-A271
GTTS-WQ10298MR	IVTScrip™ mRNA-Anti-PCSK9, LGT209(Cap 1, 2-Thio-UTP, 30 nt-poly(A))	mRNA	LGT209
GTTS-WQ4723MR	IVTScrip™ mRNA-Anti-IL21, BOS161721(Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))	mRNA	BOS161721

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST